is believed to occur at two distinct levels (32). The receptor(s) involved in viral entry are 37 presumably present only on hepatocytes and govern species specificity (11). In addition, 38 viral biosynthesis is restricted in a tissue and cell-type specific manner because HBV 39 transcription is dependent on liver-enriched transcription factors (39, 40) . A variety of 40 nuclear receptors have been shown to regulate HBV pregenomic 3.5kb RNA synthesis 41
and hence viral replication (28, 29, 33) . Three of these nuclear receptors, RXR, PPAR and 42 FXR, are ligand dependent transcription factors that are activated by retinoids, 43 peroxisome proliferators and bile acids, respectively (23,25). Therefore it is apparent that 44 the ligands for these nuclear receptors might be critical determinants of viral biosynthesis 45 under both normal and pathophysiological conditions within the liver of infected 46 individuals (12,34). 47
As the ligand-activated heterodimeric nuclear receptors, RXRα/PPARα and 48 RXRα/FXRα, regulate HBV pregenomic RNA synthesis by the recruitment of 49 coactivators, it was of interest to evaluate the relative contribution of the individual 50 heterodimeric partners to the overall level of viral transcription and replication 51 (28, 29, 44) . Characterization of the relative role of individual polypeptides to the 52 transcriptional activity of various heterodimeric nuclear receptors has been evaluated 53 (9,10,37). This approach indicated that one partner might play a dominant role in 54 controlling promoter activity depending on the nuclear receptors involved (9,10,37). 55 to the modest nature of the effects in HepG2 cells (Fig. 1C) , it is not possible to 135 conclusively determine the relative roles of the various nuclear receptors and their ligands 136 in HBV biosynthesis without examining their effects in a more tractable system. 137
Ligand-activated RXRα supports HBV biosynthesis in human embryonic kidney 138
293T cells. 139
Transfection of the HBV DNA (4.1kbp) construct with the RXRα expression 140 vector into 293T cells fails to support HBV transcription and replication in the absence of 141 ligand ( Fig. 2A and C, lanes 1 and 2) . Activation of RXRα by all-trans retinoic acid, 142 presumably by its isomerization to 9-cis retinoic acid (13,20), or 9-cis retinoic acid 143 treatment of the 293T cells resulted in a dose-dependent induction of both HBV RNA and 144 DNA synthesis (Fig. 2) . The half maximal induction of HBV biosynthesis was observed 145 at approximately 1.6 µM 9-cis retinoic acid and 3.6 µM all-trans retinoic acid (Fig. 2) . 146
The relatively high concentrations of retinoids required to activate RXRα suggest that 147 RAR, which can be activated by both all-trans and 9-cis retinoic acid construct into 293T cells in the presence of retinoid acid fails to support HBV 160 transcription and replication ( Fig. 3A and B, lanes 1 and 2) . In addition, the exogenous 161 expression of RXRα also failed to support HBV biosynthesis in the absence of retinoic 162 acid in 293T cells (Fig. 3A and B, lane 3) . However, the exogenous expression of RXRα 163 in the presence of retinoic acid is sufficient to support robust HBV transcription and 164 replication ( Fig. 3A and B, lane 4) . To address the potential role additional nuclear 165 receptors might have in governing HBV biosynthesis in 293T cells, several potential 166 heterodimer partners were over-expressed in the presence of a constant amount of co-167 expressed RXRα polypeptide (Fig. 3A and B, lanes 5-11) Fig. 3A and B, lanes 7, 8, 10 and 11) suggesting that in the absence of their 172 ligands these nuclear receptors did not affect viral transcription and replication (Fig. 3C) . 173
Interesting, over-expression of RARα inhibited RXRα-mediated HBV biosynthesis ( completely dependent on the activation of exogenously expressed nuclear receptors by 268 their cognate ligands was exploited (Fig. 2-4) . 269 HBV transcription and replication in the human embryonic kidney cell line, 293T, 270 required the ligand-dependent activation of exogenously expressed RXRα (Fig. 2) RXRα were evaluated for their effects on retinoic acid-activated RXRα-mediated HBV 298 RNA and DNA synthesis (Fig. 3) . Interestingly, FXRα, PPARα, LXRα and CAR failed 299 to modulate ligand-activated RXRα-mediated HBV transcription and replication (Fig. 3) . 300
In contrast, RARα and PXR inhibited ligand-activated RXRα-mediated HBV 301 biosynthesis (Fig. 3) . The observation that RARα inhibited retinoic acid-activated 302
RXRα-mediated HBV biosynthesis is consistent with the suggestion that RXRα/RARα 303 heterodimers activate transcription when bound to direct repeat 5 (DR5) transcriptional 304 regulatory elements but repress transcription when bound to DR1 transcriptional 305 regulatory elements (16,17). As the HBV nucleocapsid promoter contains a functional 306 DR1 transcriptional regulatory element that binds various nuclear receptors but lacks a 307 known functional DR5 transcriptional regulatory element (31,33,40), it appears that the 308 binding of an RXRα homodimer to this DR1 element activates viral transcription 309 whereas the binding of an RXRα/RARα heterodimer represses HBV biosynthesis (Fig.  310 3). The observation that the expression of CAR, which binds to DR5 transcriptional 311 regulatory elements as a RXR/CAR heterodimer (1,6), did not affect ligand-activated 312
RXRα-mediated HBV biosynthesis is also consistent with this suggestion (Fig. 3) . The observation that FXRα and PPARα failed to enhance retinoic acid-activated 332
RXRα-mediated HBV biosynthesis in the absence of their cognate ligands (Fig. 3)  333 questioned the importance of their role in HBV biosynthesis. However in the absence of 334 retinoic acid, bile acids and peroxisome proliferators activated HBV biosynthesis 335 demonstrating that these ligands were critical determinants of viral pregenomic RNA 336 synthesis as part of the RXRα/FXRα and RXRα/PPARα heterodimer complexes, 337 respectively (Fig. 4) . Inclusion of both ligands for either nuclear receptor heterodimer 338 combination did not synergistically enhance HBV RNA and DNA synthesis suggesting 339 that activation of any one partner in the heterodimer was sufficient to induce the majority 340 of the potential transcriptional activity associated with the two nuclear receptor 341 polypeptides. A further modest enhancement of transcriptional activity was apparent 342 when the second ligand was included but overall these results suggest that the activation 343 of a single nuclear receptor by ligand binding is sufficient to support most of the 344 observed RNA synthesis from the HBV nucleocapsid promoter. These observations 345 suggest that either a single nuclear receptor within the heterodimer is capable of 346 recruiting the majority of the transcriptional machinery necessary for maximal promoter 347 activity or the activation of one partner by ligand binding leads to the activation of the 348 other partner presumably by appropriate allosteric interactions (7,9,10,37). 
